“…It is possible that cyclic GMP is involved in the cellular mechanisms of adrenergic-cholinergic antagonism in cardiac ventricles. Several lines of evidence accumulated over the past 2 decades indicate that activation of muscarinic cholinergic receptors antagonizes the inotropic (Levy, 1971;Watanabe and Besch, 1975;Levy, 1977), electrophysiological (Kent et al, 1973;Watanabe et aL, 1978a;Bailey et al, 1979), and metabolic (Gardner and Allen, 1976;Hess et al, 1962;Murad et aL, 1962;LaRaia and Sonnenblick, 1971;Wilkerson et al, 1976;Keeley et al, 1978;Lindemann et al, 1979;Watanabe et al, 1978b) effects of /S-adrenergic receptor stimulation. We previously suggested that this effect of acetylcholine might be mediated partially through cyclic GMP, because the choline ester antagonized the inotropic effects of isoproterenol without attenuating the amount of cyclic AMP formed in response to /?-adrenergic receptor stimulation, and these effects of acetylcholine were mimicked by dibutyryl cyclic GMP (Watanabe and Besch, 1975).…”